SI
Sigachi Industries Ltd (SIGACHI)
₹29.83
Mkt cap
₹1,131 Cr
P/E ratio
50.30
P/B
2.19
Div yield
0.34%
ROE
5.78%
ROCE
6.14%
EPS (TTM)
₹0.59
Book value
₹14
52W range
17–41
Sector
Healthcare
Price history
Previous close
Incorporated in 1989, Sigachi Industries Ltd is a manufacturing and selling of MCC. [1]
NSE SIGACHIBSE 543389
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthHigh
TechnicalsNeutral
52-week range
−26.98% from high₹30
₹17+79.16% from low₹41
Current
₹29.83
Prev close
₹28.90
Day
+3.22%
Price performance
1D
+3.22%
1W
+3.68%
1M
−8.36%
3M
+36.77%
6M
+54.32%
1Y
−21.69%
YTD
−4.82%
Financials
Revenue, profit & margin
P/E ratio
50.3×
SIGACHI is 46% above the sector median of 34.6×
SIGACHI50.3×
Sector median34.6×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 84.70 | 99.18 | 110.95 | 104.13 | 95.71 | 124.90 | 139.42 | 128.20 | 128.25 | 110.48 | 117.21 | 121.90 | 121.27 | |
| Expenses | 68.39 | 77.76 | 88.36 | 87.80 | 74.69 | 107.67 | 106.25 | 99.65 | 104.14 | 102.96 | 111.49 | 105.49 | 104.76 | |
| Operating Profit | 16.31 | 21.42 | 22.59 | 16.33 | 21.02 | 17.23 | 33.17 | 28.55 | 24.11 | 7.52 | 5.72 | 16.41 | 16.51 | |
| OPM % | 19.26% | 21.60% | 20.36% | 15.68% | 21.96% | 13.80% | 23.79% | 22.27% | 18.80% | 6.81% | 4.88% | 13.46% | 13.61% | |
| Other Income | 1.63 | 1.11 | 1.71 | 7.24 | 1.68 | 14.64 | 2.02 | 2.19 | -117.07 | 7.15 | -0.26 | 0.21 | 1.00 | |
| Interest | 1.27 | 1.79 | 1.84 | 2.87 | 3.16 | 2.10 | 3.82 | 3.33 | 3.31 | 3.13 | 3.13 | 4.33 | 3.01 | |
| Depreciation | 1.96 | 2.52 | 2.82 | 3.49 | 3.15 | 3.22 | 4.67 | 4.74 | 4.72 | 4.11 | 4.18 | 4.57 | 4.41 | |
| Profit before tax | 14.71 | 18.22 | 19.64 | 17.21 | 16.39 | 26.55 | 26.70 | 22.67 | -100.99 | 7.43 | -1.85 | 7.72 | 10.09 | |
| Tax % | 26.04% | 17.01% | 18.02% | 11.85% | 22.21% | 20.83% | 23.22% | 28.67% | -0.02% | -41.59% | -98.92% | 0.78% | 19.33% | |
| Net Profit | 10.88 | 15.12 | 16.10 | 15.17 | 12.76 | 21.01 | 20.51 | 16.18 | -100.97 | 10.53 | -0.01 | 7.65 | 8.15 | |
| EPS in Rs | 0.35 | 0.49 | 0.50 | 0.46 | 0.40 | 0.65 | 0.64 | 0.35 | -2.63 | 0.28 | 0.01 | 0.20 | 0.18 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −1.76% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 13 Aug '26◦ |
| Earnings day | −1.76% |
| +1 day | −5.11% |
| +5 days | +8.21% |
| +15 days | +25.10% |
| +30 days | +3.60% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Jun 202636.69%Promoter
Promoters36.69%
FIIs1.25%0.06
Public62.05%0.04
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,837.30 | 34.90 | 4,40,830 | 0.87% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| Divi's Lab. | ₹9,375.00 | 83.54 | 2,48,877 | 0.32% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,840.00 | 82.51 | 1,84,098 | 0.79% | 566 | +5.79% | 4,921 | +54.85% | 15.19% |
| Zydus Lifesci. | ₹1,160.00 | 23.77 | 1,15,710 | 0.09% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Cipla | ₹1,394.50 | 31.48 | 1,12,656 | 0.93% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| Laurus Labs | ₹1,954.00 | 96.56 | 1,05,577 | 0.10% | 362 | +125.49% | 2,026 | +29.10% | 17.76% |
| Aurobindo Pharma | ₹1,734.00 | 26.39 | 99,771 | 0.23% | 1,032 | +28.11% | 9,150 | +16.30% | 12.86% |
| Sigachi Indust. | ₹29.60 | 50.31 | 1,131 | 0.34% | 8 | −65.87% | 121 | −5.44% | 6.14% |
| Median: 158 Co. | ₹433.90 | 34.56 | 2,205 | 0.08% | 13 | +29.57% | 164 | +18.57% | 14.96% |
Filings
Annual reports6
Concall transcripts48
TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptJun 2026PPTJun 2026RECJun 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptOct 2025PPTOct 2025RECOct 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptJun 2025PPTJun 2025RECJun 2025TranscriptJan 2025PPTJan 2025TranscriptNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024
Credit ratings6
Announcements5
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 16 Sep - EGM voting results: shareholders rejected authorised capital increase and issue of 11,00,00,000 convertible warrants.Shareholder Meeting / Postal Ballot-Outcome of EGM 15 SepAnnouncement under Regulation 30 (LODR)-Newspaper Publication 11 SepCorrigendum To The Notice Of Extraordinary General Meeting To Be Held On Tuesday,September 15, 2026 At 11.00 Am 9 SepAnnouncement under Regulation 30 (LODR)-Newspaper Publication 8 Sep